Ignite Creation Date:
2024-05-06 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05697237
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-25
First Post:
2022-12-21
Brief Title:
Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cholangiocarcinoma |
Keywords: